Matthias Schroff

Chief Operating Officer at Exicure Operating Co.

Matthias Schroff

Matthias Schroff

Chief Operating Officer at Exicure Operating Co.

Overview
Career Highlights

Exicure Operating Co.
Exicure, Inc.
Vaximm AG

RelSci Relationships

422

Number of Boards

2

Relationships
RelSci Relationships are individuals Matthias Schroff likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Exicure Operating Co.

Relationship likelihood: Strong

Co-Founder at Exicure Operating Co.

Relationship likelihood: Strong

Former Chief Financial Officer & Head-Investor Relations at Mologen AG

Relationship likelihood: Strong

Former Chief Medical Officer at Mologen AG

Relationship likelihood: Strong

Chief Financial Officer at Exicure Operating Co.

Relationship likelihood: Strong

Vice President, Head of Business Development at Exicure Operating Co.

Relationship likelihood: Strong

Co-Founder, Chairman at Exicure, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Mologen AG

Relationship likelihood: Strong

Co-Founder at Quanterix Corp.

Relationship likelihood: Strong

Former Chief Financial Officer at Mologen AG

Relationship likelihood: Strong

Paths to Matthias Schroff
Potential Connections via
Relationship Science
You
Matthias Schroff
Chief Operating Officer at Exicure Operating Co.
Career History
Chief Executive Officer
2005 - 2015

MOLOGEN AG engages in the research and clinical development of drugs in the fields of oncology and infectious diseases. Its products include lefitolimod and its follow-up molecules EnanDIM, and cell-based therapeutic vaccine MGN1601. The company was founded by Matthias P. Schlichting and Burghardt Wittig on January 14, 1998 and is headquartered in Berlin, Germany.

Chief Executive Officer
2016 - 2017

Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland.

Chief Operating Officer
2018 - Current

Exicure, Inc. engages in the provision of clinical stage biotechnology company. It offers 3-dimensional, spherical nucleic acid architecture unlocks the potential of nucleic acid therapeutics. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL.

Boards & Committees
Member, Executive Board
2005 - 2015
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Matthias Schroff. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Matthias Schroff's profile does not indicate a business or promotional relationship of any kind between RelSci and Matthias Schroff.